Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

14.10

+0.54 (3.98%)

Aug 14, 2025, 11:45 AM - Market open

Mineralys Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	919	613	354	-	-	-
Market Cap Growth	51.81%	73.31%	-	-	-	-
Enterprise Value	541	349	100	-	-	-
Last Close Price	13.56	12.31	8.60	-	-	-
PB Ratio	2.58	3.20	1.47	-	-	-
P/TBV Ratio	2.59	3.20	1.47	-	-	-
Debt / Equity Ratio	-	-	-	-	-	-1.25
Quick Ratio	-	13.53	22.57	13.65	2.10	0.28
Current Ratio	-	14.02	23.77	13.98	2.20	0.29
Return on Equity (ROE)	-	-82.24%	-41.38%	-53.00%	-1568.96%	-
Return on Assets (ROA)	-	-52.56%	-28.91%	-31.34%	-185.60%	-
Return on Capital (ROIC)	-40.19%	-55.62%	-30.45%	-34.99%	-335.62%	-
Earnings Yield	-21.59%	-29.02%	-20.34%	-	-	-
FCF Yield	-	-27.16%	-22.96%	-	-	-
Buyback Yield / Dilution	-25.20%	-34.13%	-600.33%	-3.67%	-7.64%	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q